---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-037235"
form_type: "8-K"
ticker: "ARDT"
cik: "0001756655"
company_name: "Ardent Health, Inc."
filed_at: "2024-08-14T23:59:59+00:00"
generated_at: "2026-05-31T09:22:51.396602+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Ardent Health Q2 revenue $1.47B, adj. EBITDA $122M (+20%); issues FY24 guidance

## Summary
- Q2 revenue $1.47B (+7.5% YoY); net income attributable $43M ($0.34/share).
- Adjusted EBITDA $122M, up 20% YoY; adjusted admissions +3.4%.
- Full-year 2024 guidance: revenue $5.75-5.90B, Adj. EBITDA $415-435M.
- Cash from ops $120M (+$77M YoY); prepaid $100M term loan; net leverage 2.3x.
- IPO net proceeds $209M (13.8M shares at $16); pro forma liquidity ~$832M.

## SEC filing metadata
- accession: 0001628280-24-037235
- form_type: 8-K
- ticker: ARDT
- cik: 0001756655
- company_name: Ardent Health, Inc.
- filed_at: 2024-08-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1756655/000162828024037235/0001628280-24-037235-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1756655/000162828024037235/ardt-20240814.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-037235
- JSON: https://secwatch.observer/filing/0001628280-24-037235.json
- Plain text: https://secwatch.observer/filing/0001628280-24-037235.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.